Company Description
Mirion Technologies, Inc. provides radiation detection, measurement, analysis, and monitoring products and services in North America, Europe, and the Asia Pacific.
It operates in two segments, Medical, and Nuclear & Safety. The Medical segment offers radiation oncology quality assurance and dosimetry solutions; patient safety solutions for diagnostic imaging and radiation therapy centers; radiation therapy quality assurance solutions for calibrating and verifying imaging and treatment accuracy; and radionuclide therapy products for nuclear medicine applications, such as product handling, medical imaging furniture, and rehabilitation products.
This segment improves the quality and safety of cancer care delivery; and supports applications across medical diagnostics and practitioner safety.
The Nuclear & Safety segment focuses on addressing critical radiation safety, measurement, and analysis applications; and provides personal radiation detection, identification equipment, and analysis tools.
The company’s products and solutions also include radiation measurement and monitoring solutions, reactor instrumentation and control detectors, imaging systems and cameras, and waste management systems; laboratory and scientific analysis systems comprising gamma/alpha spectroscopy, alpha/beta counting, specialty detectors, and spectroscopy software; radiation measurement and health physics instrumentation; and contamination and clearance monitors.
It serves hospitals, clinics and urgent care facilities, dental and veterinary offices, radiation treatment facilities, OEMs for radiation therapy, laboratories, military organizations, government agencies, industrial companies, power and utility companies, reactor design firms, and NPPs.
The company was formerly known as Global Monitoring Systems, Inc. and changed its name to Mirion Technologies, Inc. in January 2006.
Mirion Technologies, Inc. was incorporated in 2005 and is headquartered in Atlanta, Georgia.
| Country | United States |
| Founded | 2005 |
| Industry | Specialty Industrial Machinery |
| Sector | Industrials |
| Employees | 2,860 |
| CEO | Thomas Logan |
Contact Details
Address: 1218 Menlo Drive Atlanta, Georgia 30318 United States | |
| Phone | 770 432 2744 |
| Website | mirion.com |
Stock Details
| Ticker Symbol | MIR |
| Exchange | NYSE |
| Stock Type | Common Stock |
| Share Class | Class A Shares |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001809987 |
| CUSIP Number | 60471A101 |
| ISIN Number | US60471A1016 |
| Employer ID | 83-0974996 |
| SIC Code | 3829 |
Key Executives
| Name | Position |
|---|---|
| Thomas D. Logan | Founder, Medical Group President, Chief Executive Officer and Chairman |
| Brian Schopfer | Chief Financial Officer |
| Loic Eloy | Group President of Technologies |
| Christopher Moore CPA | Chief Accounting Officer |
| James Francis Charles Cocks | Chief Technology Officer |
| Emmanuelle Lee J.D. | Chief Legal Officer, Chief Compliance Officer and Secretary |
| Erin Schesny | Chief Marketing Officer |
| Alison Ulrich | Chief Human Resources Officer |
| Shelia Webb | Chief Digital Officer |
| Mark Siviter | Chief Revenue Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 21, 2025 | 8-K | Current Report |
| Feb 26, 2025 | 10-K | Annual Report |
| Feb 11, 2025 | 8-K | Current Report |
| Jan 23, 2025 | 144 | Filing |
| Dec 23, 2024 | 144 | Filing |
| Dec 18, 2024 | SCHEDULE 13D/A | Filing |
| Dec 3, 2024 | 8-K | Current Report |
| Nov 26, 2024 | 144/A | Filing |
| Nov 25, 2024 | 144 | Filing |
| Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |